• Raised $1M Convertible Note
  • Expanded scientific team with 2 new scientists (total 5 FTEs)
  • Awarded NIH CRP SB1 grant ($500K/1Y)
  • EM V2 patent filed and published (US and PCT)
  • Held Pre-IND Meeting with FDA CBER